Vol 10 - N° 4 - octobre 2018
P. 467-504© SPLF
Thoracic immuno-oncology
Editorial
N. Girard, M. Wislez
Rev. Mal. Respir. actual December 2018; 10(4): 467-8. Publication en ligne : 9 December 2018
Pivotal immuno-oncology trials in lung cancer
M. Pérol
Rev. Mal. Respir. actual December 2018; 10(4): 469-480. Publication en ligne : 9 December 2018
Immunotherapy in metastatic non-small cell lung cancer: The real-life data
B. Mennecier
Rev. Mal. Respir. actual December 2018; 10(4): 481-6. Publication en ligne : 9 December 2018
Quality of life of immunotherapy-treated lung cancer patients
C. Chouaid, G. Rousseau-Bussac, I. Monnet
Rev. Mal. Respir. actual December 2018; 10(4): 487-490. Publication en ligne : 9 December 2018
Immunotherapy for rare thoracic tumors
N. Girard
Rev. Mal. Respir. actual December 2018; 10(4): 491-7. Publication en ligne : 9 December 2018
Immunotherapy in NSCLC: state of the art and perspectives
X. Mignard, N. Chaabane, J. Chapron, F. Giraud, J. Arrondeau, E. Fabre, D. Damotte, M. Alifano, F. Goldwasser, M. Wislez
Rev. Mal. Respir. actual December 2018; 10(4): 498-504. Publication en ligne : 9 December 2018